Eli Lilly and Co has filed its Specialized Disclosure Report (Form SD) with the United States Securities and Exchange Commission. The report, which covers the period from January 1 to December 31, 2023, details the company's compliance with Rule 13p-1 under the Securities Exchange Act concerning conflict minerals. The Conflict Minerals Report for the year ended December 31, 2023, is now publicly available and can be accessed on Eli Lilly's investor relations website. This annual report is a requirement for disclosing the use of certain minerals that may finance armed conflict in the Democratic Republic of the Congo or adjoining countries. Eli Lilly's Executive Vice President and Chief Financial Officer, Anat Ashkenazi, signed the report on May 3, 2024.

Eli Lilly and Co has filed its Specialized Disclosure Report (Form SD) with the United States Securities and Exchange Commission. The report, which covers the period from January 1 to December 31, 2023, details the company's compliance with Rule 13p-1 under the Securities Exchange Act concerning conflict minerals. The Conflict Minerals Report for the year ended December 31, 2023, is now publicly available and can be accessed on Eli Lilly's investor relations website. This annual report is a requirement for disclosing the use of certain minerals that may finance armed conflict in the Democratic Republic of the Congo or adjoining countries. Eli Lilly's Executive Vice President and Chief Financial Officer, Anat Ashkenazi, signed the report on May 3, 2024.